Awful Jobs Report: ...
Edwards Life Sciences Corp. (EW: NYSE)
$84.57 -0.80 | -0.94%
06/01/12 - 04:02 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 1.68B | 1.45B | 1.32B | 1.24B |
| Cost of Sales | 431.80M | 351.80M | 340.40M | 364.00M |
| Gross Operating Profit | 1.25B | 1.10B | 981.00M | 873.70M |
| Selling, General, and Administrative Expenses | 642.40M | 550.00M | 508.80M | 480.60M |
| Research & Development | 246.30M | 204.40M | 175.50M | 139.20M |
| Operating Income before D & A (EBITDA) | 358.10M | 340.80M | 296.70M | 253.90M |
| Depreciation & Amortization | 58.00M | 56.50M | 58.70M | 55.60M |
| Interest Income | 3.40M | 900.00K | 1.60M | 6.10M |
| Other Income - Net | 4.80M | 8.10M | 3.70M | -7.70M |
| Special Income / Charges | -21.60M | -22.70M | 63.80M | -25.10M |
| Total Income Before Interest Expenses (EBIT) | 286.70M | 270.60M | 307.10M | 171.60M |
| Interest Expense | 3.10M | 2.40M | 2.70M | 7.20M |
| Pre-Tax Income | 283.60M | 268.20M | 304.40M | 164.40M |
| Income Taxes | 46.90M | 50.20M | 75.30M | 35.50M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | 236.70M | 218.00M | 229.10M | 128.90M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | 236.70M | 218.00M | 229.10M | 128.90M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 236.70M | 218.00M | 229.10M | 128.90M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
258.30M | 240.70M | 165.30M | 154.00M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 236.70M | 218.00M | 229.10M | 128.90M |
| Basic EPS from Continuing Ops. | 2.07 | 1.92 | 2.04 | 1.16 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 2.07 | 1.92 | 2.04 | 1.16 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 2.07 | 1.92 | 2.04 | 1.16 |
| Basic Normalized Net Income/Share | 2.26 | 2.12 | 1.47 | 1.38 |
| EPS fr Continuing Ops. | 1.98 | 1.83 | 1.95 | 1.10 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | 1.98 | 1.83 | 1.95 | 1.10 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 1.98 | 1.83 | 1.95 | 1.10 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
2.16 | 2.02 | 1.41 | 1.31 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with EW
- Portfolio NameUser Type
- ContributorRelative Strength Trades fo...
- UserThe Coming M&A boom
- Contributor3 Large-Cap Stocks Insiders...
- Contributor8 Health Care Stocks Inside...
- Contributor5 Stocks JPMorgan Warns to ...
- UserFive Star All Cap Fund
- Contributor6 Health Care Stocks to Gai...
- Contributor5 Stocks With Too Much Japa...
- Contributor10 U.S. Stocks With Big Exp...
- ProRon Baron
Latest EW Headlines from TheStreet
- Edwards Life Sciences Corp. (EW): Today's Featured Health Care Winner 05.23.12 | 05:05 pm
- Edwards Lifesciences' CEO Hosts Annual Meeting Of Stockholders Conference (Transcript) 05.10.12 | 06:05 pm
- Edwards Life Sciences Corp. (EW): Today's Featured Health Care Loser 05.10.12 | 05:05 pm
- Edwards Life Sciences Corp. (EW): Today's Featured Health Services Winner 05.02.12 | 04:05 pm
- 14 Deal-Ready Stocks for the M&A Boom 04.26.12 | 06:04 am
- Edwards Lifesciences, Apple: S&P Gainers 04.25.12 | 05:04 pm
- Edwards Lifesciences Corporation's CEO Discusses Q1 2012 Results - Earnings Call Transcript 04.24.12 | 10:04 pm
- 'Mad Money Lightning Round': Go for Edwards Lifesciences. 03.16.12 | 07:03 pm
- 3 Large-Cap Stocks Insiders Are Selling Like Crazy 02.10.12 | 12:02 pm
- Edwards Lifesciences' CEO Discusses Q4 2012 Results - Earnings Call Transcript 02.02.12 | 09:02 pm
Press Releases for EW
- East West Petroleum Enters Into Agreement With Halliburton - PR Newswire 11.21.11 | 09:11 am
- East West Petroleum Announces No Material Change - PR Newswire 11.08.11 | 01:11 pm
- East West Petroleum Announces Acquisition Of A New Exploration Block In Morocco - PR Newswire 10.06.11 | 04:10 pm
- East West Announces VP, Engineering - PR Newswire 09.14.11 | 05:09 pm
- EAST WEST PETROLEUM APPOINTS DAVID SIDOO AS EXECUTIVE CHAIRMAN - PR Newswire 05.31.11 | 07:05 pm
- EAST WEST PETROLEUM CORP SIGNS BINDING MOU WITH NIS TO DRILL 12 WELLS ON FOUR BLOCKS IN ROMANIA - PR Newswire 05.24.11 | 04:05 pm
- EAST WEST PETROLEUM WARRANTS BEGIN TO TRADE ON TSX VENTURE EXCHANGE - PR Newswire 05.05.11 | 07:05 pm
- Strategos/wRatings Innovation Index Identifies The Most Innovative Pharmaceutical And Medical Device Companies - Business Wire 05.11.10 | 08:05 am
Partner Headlines for EW
- UPDATE: Goldman Sachs Reiterates Buy Rating, Raises PT for Edwards Lifesciences - Benzinga 05.02.12 | 09:05 am
- The Best Performing S&P 500 Stocks March Through May - Seeking Alpha 04.04.12 | 08:04 am
- Medtronic May Rise 30%, Outperforming Peers - Seeking Alpha 03.30.12 | 08:03 am
- Cramer's Lightning Round - Buy Lions Gate Ahead Of Hunger Games (3/16/12) - Seeking Alpha 03.18.12 | 07:03 am
- Zacks Industry Outlook Highlights: Medtronic, Boston Scientific, St. Jude Medical, Edwards Lifesciences and Varian Medical - Press Releases - Zacks 03.07.12 | 09:03 am
- Stereotaxis Beats, Loss Widens - Analyst Blog - Zacks 03.07.12 | 09:03 am
- The Zacks Analyst Blog Highlights: Medtronic, Boston Scientific, St Jude Medical, Edwards Lifesciences and The Goldman Sachs Group - Press Releases - Zacks 02.21.12 | 09:02 am
- CE Mark for Edwards' Intuity - Analyst Blog - Zacks 02.17.12 | 04:02 pm
- Earnings Preview: Medtronic - Analyst Blog - Zacks 02.17.12 | 03:02 pm
- Goldman Sachs Maintains Buy on Edwards Lifesciences After 4Q Earnings - Benzinga 02.03.12 | 09:02 am





